1-(1-methyl-1,2,5,6-tetrahydropyridin-3-yl)-ethanol | 55806-54-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 1-(1-methyl-1,2,5,6-tetrahydropyridin-3-yl)-ethanol
• 英文别名: 1-(1-methyl-3,6-dihydro-2H-pyridin-5-yl)ethanol
• CAS: 55806-54-7
• 化学式: C₈H₁₅NO
• 分子量: 141.213
• InChiKey: MWEWIKKZVFGASK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  23.5
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  3-acetyl-1-methylpyridinium iodide 在 sodium tetrahydroborate 作用下， 以 甲醇 为溶剂， 反应 3.0h， 以88%的产率得到1-(1-methyl-1,2,5,6-tetrahydropyridin-3-yl)-ethanol
  参考文献：
  名称：

  吡啶鎓盐还原合成哌啶衍生物

  摘要：

  摘要 哌啶衍生物 1a-e 和 2a-f 是通过用 NaBH4 还原 3-和 4-取代的吡啶盐制备的，产率中等至极好。反应区域选择性地得到 1,2,5,6-四氢吡啶，产率很大程度上取决于苯环和氮原子上取代基的性质、吡啶环上取代基的性质和位置以及链芳氧基和吡啶基之间的长度。

  DOI：

  10.1080/00397910701483944

文献信息

• Novel aminopyrimidine derivatives as PLK1 inhibitors
  申请人：Hashihayata Takashi

  公开号：US20080305081A1

  公开（公告）日：2008-12-11

  The present invention relates to a compound represented by Formula [I]: or a pharmaceutically acceptable salt or ester thereof, wherein R 1 and R 2 , which may be the same or different, are each a hydrogen atom, a lower alkyl group, a cycloalkyl group, or the like; R 3 and R 4 , which may be the same or different, are each a hydrogen atom, a lower alkyl group, NR a R b , a phenyl group, a lower alkyl group substituted with a phenyl group, a 4- to 7-membered aliphatic heterocyclic group, a lower alkyl group substituted with a 4- to 7-membered aliphatic heterocyclic group, a 5- or 6-membered aromatic heterocyclic group, a lower alkyl group substituted with a 5- or 6-membered aromatic heterocyclic group, or the like; and R 5 is a hydrogen atom, a cyano group, a halogen atom, or a lower alkyl group.

  本发明涉及由公式[I]表示的化合物，或其药学上可接受的盐或酯，其中R1和R2（可以相同也可以不同）分别是氢原子、低碳基、环烷基或类似物；R3和R4（可以相同也可以不同）分别是氢原子、低碳基、NRaRb、苯基、带苯基的低碳基、4-至7-成员的脂环杂环基、带4-至7-成员的脂环杂环基的低碳基、5-或6-成员的芳香杂环基、带5-或6-成员的芳香杂环基的低碳基或类似物；R5是氢原子、氰基、卤素原子或低碳基。
• NOVEL AMINOPYRIMIDINE DERIVATIVE AS PLK1 INHIBITOR
  申请人：BANYU PHARMACEUTICAL CO., LTD.

  公开号：EP2116543A1

  公开（公告）日：2009-11-11

  The present invention relates to a compound represented by Formula [I]: or a pharmaceutically acceptable salt or ester thereof, wherein R1 and R2, which may be the same or different, are each a hydrogen atom, a lower alkyl group, a cycloalkyl group, or the like; R3 and R4, which may be the same or different, are each a hydrogen atom, a lower alkyl group, NRaRb, a phenyl group, a lower alkyl group substituted with a phenyl group, a 4- to 7-membered aliphatic heterocyclic group, a lower alkyl group substituted with a 4- to 7-membered aliphatic heterocyclic group, a 5- or 6-membered aromatic heterocyclic group, a lower alkyl group substituted with a 5- or 6-membered aromatic heterocyclic group, or the like; and R5 is a hydrogen atom, a cyano group, a halogen atom, or a lower alkyl group.

  本发明涉及一种由式 [I] 表示的化合物： 或其药学上可接受的盐或酯，其中R1和R2可以相同或不同，各自为氢原子、低级烷基、环烷基或类似物；R3 和 R4（可以相同或不同）各自是氢原子、低级烷基、NRaRb、苯基、被苯基取代的低级烷基、4-7 元脂肪杂环基、被 4-7 元脂肪杂环基取代的低级烷基、5-或 6 元芳香杂环基、被 5-6 元芳香杂环基取代的低级烷基或类似基团；R5 是氢原子、氰基、卤素原子或低级烷基。
• US7977336B2
  申请人：——

  公开号：US7977336B2

  公开（公告）日：2011-07-12
• Synthesis of Piperidine Derivatives by Reduction of Pyridinium Salts
  作者：Zilong Tang、Joelle Mayrargue、Mouad Alami

  DOI：10.1080/00397910701483944

  日期：2007.9.1

  Abstract Piperidine derivatives 1a–e and 2a–f have been prepared by the reduction of 3‐and 4‐substituted pyridinium salts with NaBH4 in moderate to excellent yields. The reactions regioselectively give 1,2,5,6‐tetrahydropyridines, and the yields depend greatly upon the nature of substituents on the phenyl ring and on the nitrogen atom, the nature and the position of the substituents on the pyridyl

  摘要 哌啶衍生物 1a-e 和 2a-f 是通过用 NaBH4 还原 3-和 4-取代的吡啶盐制备的，产率中等至极好。反应区域选择性地得到 1,2,5,6-四氢吡啶，产率很大程度上取决于苯环和氮原子上取代基的性质、吡啶环上取代基的性质和位置以及链芳氧基和吡啶基之间的长度。